Company Profile
Personalis Stock Price, News & Analysis
- Ticker:
- PSNL
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Personalis is followed within the biotech universe for its exposure to catalyst-driven execution.
Stock performance
10.06 USD (-1.08%)
Close
Last updated: June 23, 2026 at 00:00
1.05B USD
Market cap
Why the stock is moving
PSNL is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Personalis is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Personalis is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
Personalis follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, Personalis sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
- 02
- 03
- 04
- 05
Personalis to Participate in Upcoming Investor Events
Source: Personalis
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Personalis (PSNL)?
Personalis (PSNL) most recently closed at 10.06 USD, a -1.08% move versus the previous session.
What is the market cap of Personalis (PSNL)?
Personalis currently has a market capitalization of 1.05B USD on BioPharmSignal.
What does Personalis do?
Personalis is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is PSNL stock listed?
Personalis (PSNL) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Personalis is followed within the biotech universe for its exposure to catalyst-driven execution., Biotechnology.
What is Personalis?
Personalis is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
Which conditions is Personalis targeting with Personalis?
Personalis is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.